CMPX

COMPASS THERAPEUTICS INC

CMPX·20454B104·US·Common Stock·Healthcare - Biotechnology-Activist

CMPX (COMPASS THERAPEUTICS INC) is held by 125 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($24.7M), STATE STREET CORP ($21.8M), VANGUARD CAPITAL MANAGEMENT LLC ($13.4M). Net institutional sentiment: Bullish.

125
Holders
(10 Elite)
$171.5M
Total Value
67% (128)
Consensus
86 buying - 42 selling
13F: Insider & Congress: Updated regularly
CMPX

Smart Money Verdict

View all
Loading verdict
Held by 125 funds
10 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Apr 30, 2026 · Activists Aug 14, 2026 · Congress none

ActivistVOVivo Opportunity Fund Holdings, L.P.4.0%Aug 14, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.5%Aug 7, 2026
ActivistBLBVF PARTNERS L P/IL4.3%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.3M(+18.7%)$24.7M0.0%-4.30%
34
Increased
10M(+48.7%)$21.8M0.0%-29.25%
39
Increased
6.1M(+1.4%)$13.4M0.0%-55.70%
28
Increased
4.7M(+457.0%)$10.3M0.0%+1.04%
45
Increased
3.8M(+7.0%)$8.4M0.0%-24.74%
29
Increased
3.8M(+248.3%)$8.3M0.0%-22.83%
44
Increased
3.7M(+44.6%)$8.1M0.0%-45.78%
37
Increased
3.6M(+395.0%)$7.8M0.0%-13.65%
44
Increased
3.5M(+77.0%)$7.7M0.0%-30.10%
42
Increased
3.5M(+1650.8%)$7.7M0.0%+4.27%
44
Increased
1.4M(+3.2%)$3M0.0%-55.21%
27
Decreased
1.3M(-17.5%)$2.9M0.0%-55.85%
0
Decreased
1.2M(-32.7%)$2.7M0.0%+64.00%
0
Decreased
1.2M(-86.0%)$2.6M0.0%-39.60%
0
Increased
1.1M(+8.8%)$2.5M0.0%-27.30%
28
Increased
1M(+247.3%)$2.2M0.0%+8.52%
42
Increased
1M(+1906.9%)$2.2M0.0%+6.37%
42
Increased
1M(+0.3%)$2.2M0.0%-55.98%
26
Decreased
899,936(-51.6%)$2M0.0%-20.28%
0
New
807,004$1.8M0.0%+10.96%
36

Showing 1-20 of 136

1 / 7
CMPXCMPXCOMPASS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used